PMID- 21518483 OWN - NLM STAT- MEDLINE DCOM- 20120112 LR - 20161125 IS - 1009-2137 (Print) IS - 1009-2137 (Linking) VI - 19 IP - 2 DP - 2011 Apr TI - [Chimeric Ad5F35 adenoviral vector-mediated expression of mutant IkappaBalpha induces apoptosis of leukemia cells]. PG - 332-6 AB - Constitutive activation of nuclear transcription factor-kappaB (NF-kappaB) exists in a variety of leukemia, and induction of apoptosis through blocking NF-kappaB activation may be an alternative strategy for leukemia treatment. The aim of this study was to investigate the inducing effect of modified adenovirus 5-based adenovirus vector (i.e. chimeric Ad5F35 Vec)-mediated expression of mutant IkappaBalpha (IkappaBalphaDN) on apoptosis of HL-60 cells. The recombinant Ad5F35-IkappaBalphaDN Vec carrying IkappaBalphaDN cDNA which deleted the first 1-70 amino acids coding sequences at 5' terminal of human IkappaBalpha was transfected into HL-60 cells. The apoptosis, NF-kappaB DNA binding activity, the expressions of IkappaBalpha, cIAP-2 and xIAP in HL-60 cells were detected by DNA binding assay, flow cytometry, real-time quantitative polymerase chain reaction and Western blot respectively. The results showed that apoptosis rates were 22.53 +/- 2.999%, 6.08 +/- 2.464% and 4.86 +/- 1.366% for Ad5F35-IkappaBalphaDN Vec-infected or blank vector of Ad5F35-EGFP Vec-transfected and untransfected HL-60 cells respectively, which showed a significant difference between Ad5F35-IkappaBalphaDN Vec-transfected and untransfected cells (p < 0.001) and between Ad5F35-IkappaBalphaDN Vec-transfected and Ad5F35-EGFP Vec-transfected cells (p < 0.001, p < 0.002), while NF-kappaB DNA binding activity was decreased, the truncated IkappaBalpha was expressed, and IkappaBalpha mRNA expression was up-regulated, but the expression of cIAP-2 and xIAP mRNA was down-regulated after transduction for 48 hours. It is concluded that the chimeric Ad5F35 Vec can effectively mediate the expression of IkappaBalphaDN cDNA in HL-60 cells, leading to the inhibition of NF-kappaB DNA binding activity and inducing apoptosis of HL-60 cells. FAU - Wang, Guang-Ping AU - Wang GP AD - Department of Hematology, Central South University, Changsha, Hunan Province, China. guangpingw@yahoo.com FAU - Wang, Kai AU - Wang K FAU - Xin, Hong-Ya AU - Xin HY FAU - Duan, Zhao-Jun AU - Duan ZJ FAU - Jing, Zhao-Zheng AU - Jing ZZ FAU - Tan, San-Qing AU - Tan SQ FAU - Qi, Zhen-Hua AU - Qi ZH FAU - Chen, Fang-Ping AU - Chen FP LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhongguo Shi Yan Xue Ye Xue Za Zhi JT - Zhongguo shi yan xue ye xue za zhi JID - 101084424 RN - 0 (I-kappa B Proteins) RN - 0 (NF-kappa B) RN - 0 (NFKBIA protein, human) RN - 139874-52-5 (NF-KappaB Inhibitor alpha) SB - IM MH - Adenoviridae/genetics MH - *Apoptosis MH - Genetic Vectors MH - HL-60 Cells MH - Humans MH - I-kappa B Proteins/*genetics MH - NF-KappaB Inhibitor alpha MH - NF-kappa B/*genetics MH - Transfection EDAT- 2011/04/27 06:00 MHDA- 2012/01/13 06:00 CRDT- 2011/04/27 06:00 PHST- 2011/04/27 06:00 [entrez] PHST- 2011/04/27 06:00 [pubmed] PHST- 2012/01/13 06:00 [medline] AID - 1009-2137(2011)02-0332-05 [pii] PST - ppublish SO - Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Apr;19(2):332-6.